gene editing
DARPA program managers said they are developing different testing modalities that are crucially linked in their objective to facilitate more comprehensive and faster testing.
NIH Awards $249M to Seven Firms for Rapid Acceleration of COVID-19 Diagnostics
The seven technologies feature different methods, including CRISPR and microfluidics, and can be performed in many settings and with a variety of sample types.
Startup CRISPR Firm Caspr Biotech Developing COVID Dx Using New Extremophile Bacteria Nuclease
Caspr's assay can be transported at room temperature and performed without complex external equipment, making it ideal for low-resource environments.
Broad Institute Researchers Develop Viral Detection Platform Based on Microfluidics, CRISPR Tech
The platform can detect a single virus in more than 1,000 samples at a time or more than 160 viruses, including SARS-CoV-2, in a small number of samples.
The company is in talks with potential partners in the US and China to validate the assay on clinical samples and deploy it at a large scale.